WORK
Qrons
Inc.
Work
Qrons, a preclinical biotech company is engaged in research to find treatment to combat neurological injuries. Already publicly traded, the start-up came to EliteStart to develop the brand’s story: to take the founder’s passion, intelligence and unique business perspective to attract investors and research partners.
Qrons, a preclinical biotech company is engaged in research to find treatment to combat neurological injuries. Already publicly traded, the start-up came to EliteStart to develop the brand’s story: to take the founder’s passion, intelligence and unique business perspective to attract investors and research partners.
Qrons, a preclinical biotech company is engaged in research to find treatment to combat neurological injuries. Already publicly traded, the start-up came to EliteStart to develop the brand’s story: to take the founder’s passion, intelligence and unique business perspective to attract investors and research partners.
Project Highlight
Strengthened appeal of company’s vision to investors and research partners; secured research support of Dartmouth College; successfully raised investor engagement and site traffic retention.
Depicting Qrons’ mark graphically strengthens the brand’s visual style—uncomplicated and effective.
The strategy was to pair concise messaging with a clean design to direct users to the areas most relevant to their interests.
Designed for mobile-first users, the clean design along with concise messaging, the site directs users quickly to content most relevant to their interests.
We designed an elegant mark to represent the company’s research focus of traumatic brain injury. Emphasizing the “Q” with a controlled typography pulls the logo together.
New Scientific Tools to Treat
Neuronal Injuries
